Processing the protocol with id 184
##########################################
Searching for the item "2a Scientific background and explanation of rationale..."
This part was defined, probably, at this section: 1.3 Background Pharmacologic Information on CPT 11 and OXAL 
For more information about the rationales, go to sections:
1.8 Rationale for the Regimens Chosen for Evaluation in This Study 
I have not found anything about the previous studies from titles, lets take a look for the introduction
Previous studies: FOUND
Occurrences in the text:
38032	Phase I 	"... As the activity data from the  Phase I trial of the Rhone Poulenc..."
17631	phase I 	"... profile of OXAL was evaluated in a phase I intra patient escalation  study..."
20732	phase I 	"... in  every 6 week cycles. In the phase I study, a 17% response rate ..."
21308	phase I 	"... the Mayo CPT 11 regimen  from a phase I trial (48). The recommended..."
30089	phase I 	"... limiting myelosuppression in their phase I trial (57).  All patients were..."
16278	Phase II 	"...                         9 Addendum 22  Phase II Studies of CPT 11 Weekly for..."
29585	Phase II 	"... 85 mg/m2 and CPT 11  175 mg/m2.  1.63 Phase II Clinical Trials  Scheithauer..."
30822	Phase II 	"... metastatic colorectal  cancer.  In a Phase II trial funded by Rhone Poulenc..."
38807	Phase II 	"... schedule was based on a  115 patient, Phase II trial in Europe sponsored by..."
14566	phase II 	"...            1.41 CPT 11: A number of phase II studies have been reported in..."
15571	phase II 	"... for four of six weeks      Several phase II studies have used (26 30) CPT..."
17392	phase II 	"... the U.S., Pitot et al., determined a phase II dose of 320 mg/m2 every three ..."
17472	phase II 	"... which is somewhat lower than the phase II starting dose of 350 mg/m2 ..."
18691	phase II 	"... unchanged (33). The recommended phase II dose  was 135 mg/m2..."
19385	phase II 	"...  cancer was evaluated in five phase II trials, two with 63 previously..."
20990	phase II 	"... in 29% of  patients at the recommended phase II dose. The program is currently..."
21344	phase II 	"... a phase I trial (48). The recommended phase II dose is: CPT 11  275..."
22038	phase II 	"... from 100 to  200 mg/m2 to date. The phase II dose of CPT 11 is 180..."
22875	phase II 	"... with a 1 week rest between cycles. The phase II dose of  CPT 11 is 80 mg/m2.  ..."
26969	phase II 	"... months (p=0.8).  In two additional phase II trials, 57 and 40 patients who..."
29031	phase II 	"... one hour later. The recommended phase II dose is OXAL 200 mg/m2 and ..."
37797	phase II 	"... regimens are the only ones for which phase II data exists. The Scheithauer..."
##########################################
Searching for the item "2b Specific objectives or hypotheses"...
This part was defined, probably, at this section: 2.11 The primary objective of this trial is to compare the time to progression in patients 
Primary objectives: NOT FOUND
For more information about the secondary objectives, go to sections:
2.12 A secondary objective of this trial is to compare the time to progression of patients 
Objectives: FOUND
Occurrences in the text:
57780	evaluate 	"... s to evaluate the association of allelic variants  in five candidate genes with patient toxicity and/or..."
58006	determine 	"... s to determine whether serum levels of Insulin Like Growth  Factors 1 (IGF 1), IGF 2, and Insulin Like..."
57028	compare 	"... s to compare the time to progression in patients  with locally advanced or metastatic colorectal cancer..."
57350	compare 	"... s to compare the time to progression of patients  receiving the two experimental regimens.  The primary..."
57631	compare 	"...   To compare quality of life parameters in patients on these regimens.  2.15 Translational Studies  2.21..."
##########################################
Searching for the item "3a Description of trial design (such as parallel, factorial) including allocation ratio"...
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item "4a Eligibility criteria for participants..."
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item "5 Interventions for each group with sufficient details to allow replication, including how and when they were actually administered"
This part was defined, probably, at this section: 2.2 Treatment 
##########################################
Checking for the item “7a how sample size was determined”...
This part was defined, probably, at this section: 16.84 Sample size and power considerations: As of the implementation of Addendum 9 (which 
##########################################
Searching any information about a randomzation
This part was defined, probably, at this section: 3.18 All of the following (from the time of surgery/RT to the date of randomization): 
Maybe this information will be interesting:
96455	will be randomized	"... the existence of a consent form will be checked by Randomization  Center personnel before a patient will be randomized into this study.   Patient has given permission to store sample(s) for future..."
##########################################
Checking for the item “11a  if done, who was blinded after assignment to interventions (eg, participants, care providers, those assessing outcomes) and how.”
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item “12a  statistical methods used to compare groups for primary and secondary outcomes”
This part was defined, probably, at this section: 16.85 Statistical methods: A variety of statistical methods will be used for the different 
I found the following methods:
264532 	 log rank 	 "... rves, with hypothesis testing using the log rank test  for univariate..."
263905 	 chi square 	 "... ype or IGF status will be  tested using chi squared tests; odds ratios and..."
276715 	 fleming 	 "... in Oncol 7:425 432, 1989.  Leichman CG, Fleming TR, Muggia FM, et al: Phase II..."
288984 	 fleming 	 "... ncol 18:233 a,  1999.   78. O Brien PC, Fleming TR: A multiple testing..."
264578 	  cox  	 "... nk test  for univariate associations and Cox regression modeling for..."
264477 	 kaplan meier 	 "...  will be illustrated  graphically using Kaplan Meier curves, with hypothesis..."
